BridgeMD
New treatment option for Dyspepsia
Official title Famotidine and Antacids for Treatment of Dyspepsia
ClinicalTrials.gov ID: NCT06241183
What this study is testing
What is Intravenous Famotidine?
Intravenous Famotidine is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for dyspepsia.
Also referred to as H2 Receptor Antagonist.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study is to compare intravenous famotidine, an H2 receptor antagonist, and Maalox/ Mylanta, an oral antacid, in treatment of dyspepsia in the emergency department. The goal of this study is to reduce patients' pain based on the verbal numerical pain scale.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Subject Age ≥ 18 years of age
- Patient diagnosed with dyspepsia
- Present at the ED with upper abdominal pain score of at least 3
You likely can't join if
- Hypersensitivity to an ingredient in Maalox/ Mylanta or Famotidine
- Moderate to Severe Renal Insufficiency (precaution)
- Kidney Failure
- Pregnant or Nursing
- Verbal pain score less than 3
- Inability to tolerate oral medications
See the full eligibility criteria
- Subject Age ≥ 18 years of age
- Patient diagnosed with dyspepsia
- Present at the ED with upper abdominal pain score of at least 3
- Hypersensitivity to an ingredient in Maalox/ Mylanta or Famotidine
- Moderate to Severe Renal Insufficiency (precaution)
- Kidney Failure
- Pregnant or Nursing
- Verbal pain score less than 3
- Inability to tolerate oral medications
- Bowel Obstruction
- Proton pump inhibitor within 2 hours of study treatment
The study team makes the final eligibility decision.
Where it's taking place
- Stony Brook, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stony Brook, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.